A Martin Lerner

Summary

Publications

  1. ncbi request reprint IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital, Wayne State University School of Medicine, Royal Oak, Michigan, USA
    In Vivo 16:153-9. 2002
  2. ncbi request reprint A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function
    A Martin Lerner
    School of Medicine, Wayne State University, Detroit, MI, USA
    Drugs Today (Barc) 38:549-61. 2002
  3. ncbi request reprint IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital and Wayne State University School of Medicine, Royal Oak, Michigan, USA
    In Vivo 18:101-6. 2004
  4. ncbi request reprint Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA
    In Vivo 18:417-24. 2004
  5. ncbi request reprint Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital, Royal Oak, MI, USA
    In Vivo 21:707-13. 2007
  6. ncbi request reprint Validation of the energy index point score to serially measure the degree of disability in patients with chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, Wayne State University School of Medicine and William Beaumont Hospital, Royal Oak, MI, USA
    In Vivo 22:799-801. 2008
  7. pmc Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset
    A Martin Lerner
    Department of Medicine, Oakland University William Beaumont School of Medicine, Rochester, Michigan, United States of America
    PLoS ONE 7:e47891. 2012

Collaborators

Detail Information

Publications7

  1. ncbi request reprint IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2(UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital, Wayne State University School of Medicine, Royal Oak, Michigan, USA
    In Vivo 16:153-9. 2002
    ..Further, these data suggest an etiologic relationship for HCMV infection in this group of CFS patients...
  2. ncbi request reprint A six-month trial of valacyclovir in the Epstein-Barr virus subset of chronic fatigue syndrome: improvement in left ventricular function
    A Martin Lerner
    School of Medicine, Wayne State University, Detroit, MI, USA
    Drugs Today (Barc) 38:549-61. 2002
    ..This preliminary trial, with a small number of patients, may be critical to an appropriately designed larger, double-blind, placebo-controlled trial...
  3. ncbi request reprint IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital and Wayne State University School of Medicine, Royal Oak, Michigan, USA
    In Vivo 18:101-6. 2004
    ..A unique subset of patients with chronic fatigue syndrome (CFS) and IgM serum antibodies to cytomegalovirus (HCMV) non-structural gene products p52 and CM2 (UL 44 and UL 57) has been described...
  4. ncbi request reprint Prevalence of abnormal cardiac wall motion in the cardiomyopathy associated with incomplete multiplication of Epstein-barr Virus and/or cytomegalovirus in patients with chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA
    In Vivo 18:417-24. 2004
    ..Among the controls, ACWM at rest was present in 4 out of 191 patients (2%) (p=0.0018). A progressive cardiomyopathy caused by incomplete virus multiplication of EBV and/or HCMV in CFS patients is present...
  5. ncbi request reprint Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up
    A Martin Lerner
    Department of Medicine, William Beaumont Hospital, Royal Oak, MI, USA
    In Vivo 21:707-13. 2007
    ..42 EI units (65 kcal/day). EI point scores at Group 2 increased progressively. Sinus tachycardias decreased and abnormal cardiac wall motion improved. Serum antibody titers to EBV VCA IgM decreased. Patients resumed normal activities...
  6. ncbi request reprint Validation of the energy index point score to serially measure the degree of disability in patients with chronic fatigue syndrome
    A Martin Lerner
    Department of Medicine, Wayne State University School of Medicine and William Beaumont Hospital, Royal Oak, MI, USA
    In Vivo 22:799-801. 2008
    ..A simple quantitative accurate method for assessing the degree of fatigue in patients with chronic fatigue syndrome (CFS) is necessary for physicians and patients. Severity of the disease and recovery can, thus, be assayed...
  7. pmc Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset
    A Martin Lerner
    Department of Medicine, Oakland University William Beaumont School of Medicine, Rochester, Michigan, United States of America
    PLoS ONE 7:e47891. 2012
    ..Each patient improved, based upon the Functional Activity Appraisal: Energy Index Score Healthcare Worker Assessment (EIPS), which is a validated (FSS-9), item scale with high degree of internal consistency measured by Cronbach's alpha...